Organisation paid for research Program year 2022 Source: CMS Open Payments

Aventiv Research Inc.

Neither a doctor nor a teaching hospital

Research payments

$325,437

40 payments

Through program year 2022, Aventiv Research Inc. is reported as receiving $325,437 in research payments, across 40 payments.

By program year

4 rows
Year Kind Amount Payments
2022 Research $116,884 8
2021 Research $72,973 11
2020 Research $125,574 15
2019 Research $10,006 6

Breakdown

Who paid Research payments · program years 2019–2022
  1. Bausch Health US, LLC $153,630 9 payments
  2. Boehringer Ingelheim International GmbH $71,315 14 payments
  3. Boehringer Ingelheim Pharma GmbH & Co.KG $67,094 6 payments
  4. Akebia Therapeutics Inc $16,520 8 payments
  5. Kowa Research Institute, Inc. $13,670 2 payments
  6. Mitsubishi Tanabe Pharma Development America, Inc. $3,209 1 payment
Studies the money was for Research payments · program years 2019–2022
  1. A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Clinical Study to Compare the Safety and Efficacy of Idp-126 Gel to Epiduo? Forte Gel (0.3% Adapalene/2.5% Bpo), in the Treatment of Acne Vulgaris $153,630 9 payments
  2. Empa-Kidney $138,409 20 payments
  3. K-877-Er-201 $13,670 2 payments
  4. Akb-6548-Ci-0015 $9,688 4 payments
  5. A Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects $6,514 2 payments
  6. A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of MT-2990 in Women with Endometriosis Experiencing Endometrial Related Pain $3,209 1 payment
  7. Akb-6548-Ci-0017 $318 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record